西藏多瑞医药股份有限公司

More More More More

The group company grandly held the 2019 annual summary and commendation meeting
2020/09/29

Several key issues in the development of generic drugs
2020/08/11

video

R&D

R & D system

Since its establishment, after three years of development, fruitful results have been achieved: At present, the company has overcome many technical barriers to difficult chemical drugs, of which 5 first generic drugs with high market value are waiting to be put into production...

R & D team

There are currently 60 technicians, including 2 doctors, and 50% of them are masters and doctors. The core members have rich experience in research and development, process amplification, and technology transfer.

R & D field

It is mainly based on the raw materials of multi-chiral centers, high-tech barriers or clinically necessary emergency medicines, involving multiple therapeutic fields such as anesthesia, analgesia, and first aid.

R & D cooperation

In order to accelerate the transformation of results, it has established and maintained close cooperative relations with Chinese Academy of Medical Sciences, Shanghai Zhitong, Huazhong University of Science and Technology, Huazhong Agricultural University, Wuhan University of Technology, Southwest University, etc.

Home

Profile

Culture

News

Products

Responsibility

Human Resources

Contact Us

The group company grandly held the 2019 annual summary and commendation meeting

Several key issues in the development of generic drugs

video

culture

profile

R&D

R&D

R & D system

R & D team

R & D field

R & D cooperation

Commit to improve human health and quality of life, and to strive unremittingly for the health and happiness of mankind.

Service Hotline